The purpose of this study is to use computer simulation of an infection system to evaluate activated healthy CD4+ cell recovery (and thus therapeutic potential) in a hunter virus therapy targeted to both HIV-infected cells and free HIV virions. This evidence concerns the gene CD4 and infection.